↑ Arnerić SP, Roetker A, Long JP, Mott J, Barfknecht CF(June 1982).“Effects of semirigid methoxamine analogs on vascular smooth muscle: studies of methoxy-2-aminotetralin and 2-aminoindane derivatives”.Archives Internationales De Pharmacodynamie et De Thérapie257(2): 263–73.PMID7114973.
↑ Arnerić SP, Long JP(May 1984).“Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions”.The Journal of Pharmacy and Pharmacology36(5): 318–21.doi:10.1111/j.2042-7158.1984.tb04382.x.PMID6145768.
↑ Clark JT, Smith ER(1986).“Failure of pimozide and metergoline to antagonize the RDS-127-induced facilitation of ejaculatory behavior”.Physiology & Behavior37(1): 47–52.doi:10.1016/0031-9384(86)90382-3.PMID3737722.
↑ Rezaki YE, Ilhan M(1991).“Evaluation of alpha-adrenoceptor agonistic activity of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in rabbit and rat aortae”.Archives Internationales De Pharmacodynamie et De Thérapie310: 76–86.PMID1685313.
↑ Sahin I, Ilhan M(1988).“The antimuscarinic activity of a dopamine receptor agonist (RDS-127) differentiates M2-muscarinic receptors of heart, ileum and trachea in guinea-pig”.Archives Internationales De Pharmacodynamie et De Thérapie296: 163–72.PMID2907277.
↑ Sahin I, Tuncer M, Ilhan M(March 1990).“Dopamine receptor agonists, N,N-dipropyl-2-aminotetralin (TL-68) and 2-di-n-propylamino-4,7-dimethoxyindane (RDS-127) antagonize oxotremorine-induced tremors by antimuscarinic action in mice”.Archives Internationales De Physiologie et De Biochimie98(1): 7–9.doi:10.3109/13813459009115730.PMID1692697.
↑ Arnerić SP, Roetker A, Long JP(September 1982).“Potent anorexic-like effects of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in the rat: a comparison with other dopamine-receptor agonists”.Neuropharmacology21(9): 885–90.doi:10.1016/0028-3908(82)90080-6.PMID6897285.
↑ Kwong LL, Smith ER, Davidson JM, Peroutka SJ(October 1986).“Differential interactions of "prosexual" drugs with 5-hydroxytryptamine1A and alpha 2-adrenergic receptors”.Behavioral Neuroscience100(5): 664–8.doi:10.1037/0735-7044.100.5.664.PMID2877677.